S6IA Stock Chart & Stats
€98.40
€5.46(5.87%)
At close: 4:00 PM EDT
€98.40
€5.46(5.87%)
Day’s Range― - ―
52-Week Range€87.28 - €172.20
Previous CloseN/A
Volume13.00
Average Volume (3M)12.00
Market Cap
€12.61B
Enterprise Value€26.79K
Total Cash (Recent Filing)€748.00M
Total Debt (Recent Filing)€547.00M
Price to Earnings (P/E)10.5
Beta0.44
Next Earnings
Nov 03, 2026EPS Estimate
2.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)10.81
Shares Outstanding125,785,470
10 Day Avg. Volume1
30 Day Avg. Volume12
Financial Highlights & Ratios
PEG Ratio0.82
Price to Book (P/B)4.94
Price to Sales (P/S)1.41
P/FCF Ratio14.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€127.74Price Target Upside29.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)10.69
Revenue Forecast (FY)€15.82B
Bulls Say, Bears Say
Bulls Say
Cash GenerationLeidos' consistently strong operating and free cash flow (~$2.3B OCF, ~$2.2B FCF, ~18% FCF growth) funds capital investment, debt paydown, buybacks and strategic actions. Reliable cash conversion strengthens resilience to contract timing swings and supports multi-quarter execution.
Sustained Margins & ProfitabilityLeidos maintains robust, sustainable margins (gross ~17.5%, operating ~12.2%, net ~8.2%) and a mid‑teens adjusted EBITDA target. Strong margins improve bid competitiveness on fixed‑price work, support reinvestment and buffer earnings against cyclical federal spending shifts.
Defense Pipeline And Award MomentumHigh award velocity and a large proposals pipeline (Q2 book‑to‑bill strength, $5B booked, ~$23B proposals) give multi‑period revenue visibility. Defense tech momentum and multiple program wins create structural growth engines and optionality across space, maritime and munitions markets.
Bears Say
Elevated LeverageLeidos carries meaningful leverage (debt/equity ~1.2–1.4x; $6.0B debt, gross leverage ~2.5x). Elevated debt limits financial flexibility for large strategic investments, increases interest expense sensitivity, and raises refinancing risk if macro conditions tighten over coming quarters.
Health Segment Revenue PressureThe Health pillar faces structural headwinds after MDE contract changes and additional vendor competition, leading to sustained revenue contraction and margin pressure. Reduced growth in a material segment weakens portfolio diversification and compresses consolidated growth prospects over several quarters.
VA Incentive Suspension & In‑sourcing RiskThe VA's suspension of vendor incentives and potential MHS GENESIS in‑sourcing introduce structural uncertainty in award economics and long‑term addressable spend for health contracts. If agencies move to in‑house solutions, published margins and revenue mix could be impaired for multiple quarters.
Leidos Holdings News
S6IA FAQ
What was Leidos Holdings’s price range in the past 12 months?
Leidos Holdings lowest stock price was €87.28 and its highest was €172.20 in the past 12 months.
What is Leidos Holdings’s market cap?
Leidos Holdings’s market cap is €12.61B.
When is Leidos Holdings’s upcoming earnings report date?
Leidos Holdings’s upcoming earnings report date is Nov 03, 2026 which is in 90 days.
How were Leidos Holdings’s earnings last quarter?
Leidos Holdings released its earnings results on Aug 04, 2026. The company reported €2.828 earnings per share for the quarter, beating the consensus estimate of €2.522 by €0.305.
Is Leidos Holdings overvalued?
According to Wall Street analysts Leidos Holdings’s price is currently Undervalued.
Does Leidos Holdings pay dividends?
Leidos Holdings does not currently pay dividends.
What is Leidos Holdings’s EPS estimate?
Leidos Holdings’s EPS estimate is 2.7.
How many shares outstanding does Leidos Holdings have?
Leidos Holdings has 125,785,470 shares outstanding.
What happened to Leidos Holdings’s price movement after its last earnings report?
Leidos Holdings reported an EPS of €2.828 in its last earnings report, beating expectations of €2.522. Following the earnings report the stock price went down -7.671%.
Which hedge fund is a major shareholder of Leidos Holdings?
Currently, no hedge funds are holding shares in DE:S6IA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Leidos Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€127.74 (29.81% Upside)
€127.74 (29.81% Upside)
Blogger Sentiment
Bullish
DE:S6IA Sentiment 85%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €170.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 90%
Bearish news 10%
Bearish news 10%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.84%
12-Months-Change
Fundamentals
Return on Equity
1.47%
Trailing 12-Months
Asset Growth
16.59%
Trailing 12-Months
Company Description
Leidos Holdings
Leidos Holdings, Inc., along with its various subsidiaries, delivers a broad spectrum of services and innovative solutions across key markets: defense, intelligence, civil government, and health. The company operates both domestically within the United States and on an international scale. Its operations are organized into three principal divisions: Defense Solutions, Civil, and Health. The Defense Solutions segment is dedicated to providing national security systems and specialized support spanning air, land, sea, space, and cyberspace domains. Its extensive client base includes the U.S. Intelligence Community, the Department of Defense, NASA, various military branches, allied foreign governments, and other federal and commercial entities within the national security sector. This division's offerings encompass advanced technology, large-scale systems integration, command and control platforms, sophisticated data analytics, logistics, robust cybersecurity defenses, and crucial intelligence analysis and operational support for critical missions. The Civil segment offers systems integration capabilities primarily to air navigation service providers, such as the Federal Aviation Administration (FAA). This involves critical programs like En Route Automation Modernization (ERAM), Advanced Technology Oceanic Procedure (ATOP), Time Based Flow Management (TBFM), Terminal Flight Data Management (TFDM), GEO-7, and Future Flight Services, as well as developing enterprise-wide information display systems. Additionally, this segment provides security detection and automation services. Its portfolio further extends to comprehensive information technology (IT) solutions, covering areas like cloud computing, mobility, application modernization, DevOps, data center operations, network upgrades, asset management, help desk support, and digital workplace enablement. Environmental, energy, and infrastructure services also fall under this division. Finally, the Health segment furnishes solutions to both federal and commercial clients globally, focusing on initiatives that promote human health and well-being. This includes services such as health information management, managed healthcare programs, digital transformation projects, and support for life sciences research and development. Leidos Holdings, Inc. was established in 1969 and is based out of Reston, Virginia.
S6IA Company Deck
S6IA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid overall financial performance with record revenue, strong margins and exceptional cash generation, plus accelerating Defense momentum and a large near-term pipeline of proposals. Management raised full-year guidance and reduced leverage while completing share repurchases and progressing strategic actions (Entrust integration, SES JV). Key negatives center on the Health segment: the VA's suspension of incentive payments, near-term revenue/margin pressure from the MDE market and some uncertainty around MHS GENESIS and agency in-sourcing trends. Management indicates these health headwinds are largely accounted for in the updated guidance and expects offset from Defense, Homeland and digital growth pillars.View all DE:S6IA earnings summariesS6IA Revenue Breakdown
44.20% National Security & Digita
30.10% Health & Civil
13.52% Commercial & International
12.18% Defense Systems

S6IA Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€127.74
▲(29.81% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month








